Crossmark

Unleashing the potential of CD39-targeted cancer therapy: Breaking new ground and future prospects

Crossref DOI link: https://doi.org/10.1016/j.biopha.2024.117285

Published Print: 2024-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Zhou, Qiongyan

Shao, Shengwen

Minev, Theia

Ma, Wenxue https://orcid.org/0000-0001-9228-6162
License Information

Text and Data Mining valid from 2024-09-01

Text and Data Mining valid from 2024-09-01

Version of Record valid from 2024-08-08
More Information

This article is maintained by: Elsevier

Article Title: Unleashing the potential of CD39-targeted cancer therapy: Breaking new ground and future prospects

Journal Title: Biomedicine & Pharmacotherapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.biopha.2024.117285

Content Type: simple-article

Copyright: © 2024 The Author(s). Published by Elsevier Masson SAS.